3'-deoxy-2',3'-didehydro-2'fluorothymidine has been researched along with 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, D; Chen, LC; Chou, TC; Huang, JT; Kim, MH; Matulic-Adamic, J; Wang, LB; Warshaw, JA; Watanabe, KA; Zhu, QY | 1 |
| Bushnell, DJ; Duncan, IB; Dunsdon, SJ; Hall, MJ; Machin, PJ; Martin, JA; Merrett, JH; Parkes, KE; Roberts, NA; Thomas, GJ | 1 |
| Brankovan, V; Ghazzouli, I; Mansuri, MM; Martin, JC; Sterzycki, RZ | 1 |
| Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV | 1 |
4 other study(ies) available for 3'-deoxy-2',3'-didehydro-2'fluorothymidine and 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine
| Article | Year |
|---|---|
Fluorinated sugar analogues of potential anti-HIV-1 nucleosides.
Topics: Animals; Antiviral Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Dideoxynucleosides; HIV-1; Humans; Mink; Structure-Activity Relationship | 1991 |
Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1).
Topics: Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Deoxyribonucleosides; Dideoxynucleosides; Fluorine; HIV-1; Humans; Lymphocytes; Molecular Structure; Pyrimidine Nucleosides; Structure-Activity Relationship; Zalcitabine | 1990 |
Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Fluorine; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; Humans; Macrophages; Molecular Structure; Monocytes; Pyrimidine Nucleosides; T-Lymphocytes; Tumor Cells, Cultured; Viral Core Proteins; Zalcitabine; Zidovudine | 1990 |
HIV-1 reverse transcriptase inhibitor design using artificial neural networks.
Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1994 |